Filter
1027
Filtered Results: 1027
Text search:
rapid
antigen
test
Featured
Recommendations
148
New Publications
274
Language
Document type
No document type
538
Guidelines
216
Studies & Reports
122
Manuals
59
Strategic & Response Plan
39
Fact sheets
27
Situation Updates
9
Training Material
5
Online Courses
4
Resource Platforms
3
Brochures
2
Infographics
2
Videos
1
Countries / Regions
India
68
Global
42
Africa
26
Nigeria
25
Western and Central Europe
24
Kenya
22
South Africa
21
Sierra Leone
18
Uganda
17
Tanzania
16
East and Southern Africa
16
Germany
15
Philippines
14
West and Central Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
13
Ethiopia
13
Zambia
13
Nepal
12
Rwanda
12
Ukraine
11
Ghana
11
Russia
11
Liberia
11
Malawi
10
Myanmar / Burma
9
Cameroon
8
Burkina Faso
8
Bangladesh
8
Brazil
8
Namibia
8
Zimbabwe
7
Middle East and North Africa
7
Lesotho
6
Eastern Europe and Central Asia
6
Eastern Europe
6
Benin
5
Syria
5
Mozambique
5
South–East Asia Region
5
Indonesia
5
Colombia
4
Senegal
4
Cambodia
4
Pakistan
4
USA
3
South Sudan
3
Madagascar
3
Iran
2
Albania
2
Niger
2
Afghanistan
2
Guinea
2
Haiti
2
Jordan
2
Saudi Arabia
2
Lebanon
2
Djibouti
2
Sudan
2
Central African Republic
2
Angola
2
Botswana
2
Iraq
2
Somalia
2
Eswatini/ Swaziland
2
North Macedonia
1
Timor Leste/ East Timor
1
Togo
1
China
1
Kazakhstan
1
Chile
1
Canada
1
Congo-Brazzaville
1
Burundi
1
Peru
1
Morocco
1
Qatar
1
Asia
1
Venezuela
1
Western Pacific Region
1
Luxembourg
1
North America
1
Belgium
1
France
1
Tunisia
1
Spain
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Libya
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
412
Clinical Guidelines
158
Pharmacy & Technologies
42
Public Health
38
Women & Child Health
19
Key Resources
19
Capacity Building
11
Toolboxes
COVID-19
174
HIV
114
TB
74
NTDs
70
Rapid Response
68
Ebola
38
Refugee
19
Pharmacy
14
Zika
13
Conflict
11
Polio
11
AMR
10
Mental Health
9
Cholera
8
Caregiver
8
NCDs
7
Natural Hazards
5
Planetary Health
5
Health Financing Toolbox
5
Specific Hazards
2
Global Health Education
1
Ce rapport présente les résultats clés de la cinquième Enquête Démographique et de Santé du Cameroun
(EDSC-V) réalisée sur le terrain du 16 juin 2018 au 19 janvier 2019, par l’Institut National de la Statistique
(INS), en étroite collaboration avec le Ministère de la Santé Publique. ...
23 Dec 2020. The aim of this document is to provide an update on the knowledge surrounding the role of children in the transmission of SARS-CoV-2 and the role of schools in the COVID-19 pandemic, based on the experience in the EU from August–December, 2020. This document also addresses transmissio...
The COVID-19 pandemic has led to large increases in healthcare waste, straining under resourced healthcare facilities and exacerbating environmental impacts from solid waste. This report quantifies the additional COVID-19 healthcare waste generated, describes current healthcare waste management syst...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
The coronavirus outbreak that began in 2019 (COVID-19) threatens to reverse years of hard-won gains in preventing and treating HIV. Fragile health systems are further stressed as health workers navigate an increased client load and demands at work while also being concerned for their own health and ...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
ECDC Technical Report
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
In line with ECDC’s recommendations provided in the ’Risk Assessment of HTLV-1/2 transmission by tissue/cell transplantation’ dated 14 March 2012, this Directive replaces the term ‘incidence’ with ‘prevalence’ in the description of endemic areas of HTLV-1/2 i...
Overwhelming evidence shows that a range of health concerns—mental illness, substance dependence, HIV/AIDS, and noncommunicable diseases—affect prisoners disproportionately. But, while incarceration poses risks to health—including inadequate nutrition and exposure to violence—prisons also pr...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
In this document, recommendations are provided on designing and implementing
a cross-sectional serosurvey using school-based sampling to estimate age-specific
DENV seroprevalence to inform a country’s national dengue vaccination program.
The document includes recommendations for methods for ...
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
The 2018 NDHS is a national sample survey that provides up-to-date information on demographic and health indicators. The sample was selected using a stratified, two-stage cluster design, with enumeration areas (EAs) as the sampling units for the first stage. The second stage was a complete listing o...
Parasites & Vectors volume 11, Article number: 264 (2018)
Dengue creates a staggering epidemiological and economic burden for endemic countries. Without a specific therapy and with a commercial vaccine that presents some problems relative to its full effectiveness, initiatives to improve vector...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
